SCHEMBL467666

SCHEMBL467666

Nc1cccc(CCCl)c1CCCl

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 4/20 0.37
TSHR P16473 3/20 0.37
PIK3CA P42336 1/20 0.37
ALDH1A1 P00352 2/20 0.35
TDP1 Q9NUW8 2/20 0.33
CD44 P16070 1/20 0.33
HPGD P15428 1/20 0.33
HSD17B10 Q99714 1/20 0.33
TAAR1 Q96RJ0 4/20 0.32
ALOX15 P16050 1/20 0.32
CASP1 P29466 1/20 0.32
CASP7 P55210 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
PNMT P11086 1/20 0.31
NR4A2 P43354 1/20 0.31
SLC6A2 P23975 1/20 0.31
SLC6A4 P31645 1/20 0.31
SLC6A3 Q01959 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11873762 0.84 MEN1 (0.39) CYP3A4TSHR
SCHEMBL11443845 0.84 GABRA1 (0.35) TSHRHSD17B10TAAR1PNMTSLC6A2
SCHEMBL11026037 0.80 CD44 (0.39) CYP3A4TSHRPIK3CAALDH1A1TDP1
SCHEMBL9304737 0.79 ALOX15 (0.43) CYP3A4TSHRALDH1A1TDP1TAAR1
SCHEMBL9057723 0.78 PNMT (0.45) TAAR1PNMT
SCHEMBL411734 0.78 NOS2 (0.37) CYP3A4TSHRPIK3CAALDH1A1TDP1
SCHEMBL30380395 0.77 TAAR1 (0.37) TAAR1PNMT
SCHEMBL5133372 0.76 CYP3A4 (0.32) CYP3A4TSHRALDH1A1TDP1ALOX15
SCHEMBL4590254 0.76 GABRA1 (0.44) CYP3A4ALDH1A1TDP1TAAR1
SCHEMBL11858483 0.76 TAAR1 (0.40) CYP3A4TSHRALDH1A1TDP1TAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020167811-A1 A CROSS-LINKING APPROACH TO MAP SMALL MOLECULE-RNA BINDING SITES IN CELLS THE SCRIPPS RESEARCH INSTITUTE (US) 2020-08-20 WO disclosed
EP-2387395-A1 AXL INHIBITORS FOR USE IN COMBINATION THERAPY FOR PREVENTING, TREATING OR MANAGING METASTATIC CANCER Rigel Pharmaceuticals, Inc. (US) 2011-11-23 EP disclosed
US-8040491-B2 Exposure method, substrate stage, exposure apparatus, and device manufacturing method NIKON CORPORATION (JP) 2011-10-18 US disclosed
WO-2010083465-A1 AXL INHIBITORS FOR USE IN COMBINATION THERAPY FOR PREVENTING, TREATING OR MANAGING METASTATIC CANCER RIGEL PHARMACEUTICALS, INC. (US) 2010-07-22 WO disclosed
EP-1807077-A2 INHIBITORS OF C-FMS KINASE JANSSEN PHARMACEUTICA N.V. (BE) 2007-07-18 EP disclosed
WO-2006047277-A2 INHIBITORS OF C-FMS KINASE JANSSEN PHARMACEUTICA, N.V. (BE) 2006-05-04 WO disclosed
US-20060019936-A1 Methods and compositions for treating cancer MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2006-01-26 US disclosed
US-4172081-A Benzotriazole ultraviolet stabilizers EASTMAN KODAK COMPANY (US) 1979-10-23 US disclosed
US-4116929-A POLYESTERS EASTMAN KODAK COMPANY (US) 1978-09-26 US disclosed
US-4017508-A POLYMERS EASTMAN KODAK COMPANY (US) 1977-04-12 US disclosed
US-3997519-A Method of producing quaternary pyridinium compounds GAF CORPORATION (US) 1976-12-14 US disclosed